TextbookPaediatrics & Child HealthHenoch-Schonlein Purpura

Henoch-Schonlein Purpura

HSP (IgA vasculitis) is the most common vasculitis of childhood, characterised by palpable purpura, arthralgia, abdominal pain, and renal involvement. It is usually self-limiting but requires monitoring for renal complications.

Key Facts

HSP (IgA vasculitis): Most common vasculitis in children; peak age 3-10 years; incidence ~20 per 100,000 children Classic tetrad: Palpable purpura (100%), arthralgia/arthritis (75%), abdominal pain (65%), renal involvement (40%) Palpable purpura on extensor surfaces (buttocks and legs) is the hallmark — must be present for diagnosis Renal involvement: Haematuria and/or proteinuria in ~40%; progresses to nephrotic syndrome or renal failure in ~5% IgA nephropathy: Same pathological process as HSP nephritis — IgA deposition in glomerular mesangium Management is mostly supportive: Analgesia, hydration; corticosteroids may help severe abdominal pain but do NOT prevent nephritis Monitor urine and BP for 6-12 months after diagnosis — renal involvement may develop late Most children recover fully within 4-6 weeks; ~30% have at least one relapse

Overview

Key Facts

HSP is the most common childhood vasculitis and is usually a benign, self-limiting condition. The most important complication is renal disease, which requires monitoring for up to 12 months after the acute episode.

Epidemiology

Incidence: approximately 20 per 100,000 children per year. Peak age: 3-10 years. Male:female ratio 1.5:1. More common in autumn/winter. Rare in adults (but when it occurs, renal involvement is more severe).

Aetiology

  • Trigger: Preceding URTI in ~50-75% of cases
  • Infections: Group A Streptococcus, adenovirus, parvovirus B19, Mycoplasma
  • Other triggers: Drugs, insect bites, food allergens
  • Pathogenesis: IgA immune complex deposition in small vessel walls

Pathophysiology

HSP is an IgA-mediated small vessel vasculitis (leucocytoclastic vasculitis). IgA1 immune complexes deposit in the walls of small blood vessels (skin, joints, gut, kidneys), causing complement activation, neutrophil infiltration, and vessel wall damage. In the kidneys, IgA deposition in the glomerular mesangium causes a proliferative glomerulonephritis identical to IgA nephropathy.

Clinical Presentation

Classic Tetrad

  1. Purpura (100%): Palpable, non-thrombocytopenic purpura on buttocks and lower limbs (extensor surfaces); may also affect arms and trunk
  2. Arthralgia/arthritis (75%): Knees and ankles most commonly; periarticular swelling; non-deforming
  3. Abdominal pain (65%): Colicky; may be severe; GI bleeding (melaena, haematemesis) in 20-30%
  4. Renal (40%): Microscopic haematuria, proteinuria; macroscopic haematuria in ~5%; nephrotic syndrome rarely

Other Features

  • Scrotal swelling/pain (~15% of boys — may mimic testicular torsion)
  • Subcutaneous oedema (face, hands, feet — especially in young children)
  • Rarely: CNS involvement (headache, seizures, altered consciousness)

Red Flags

  • Heavy proteinuria (uPCR >200) — risk of nephrotic syndrome/renal impairment
  • Hypertension — renal involvement
  • Severe abdominal pain with bloody stool — consider intussusception (ileo-ileal, not the ileocolic type seen in typical intussusception)
  • Scrotal pain — exclude testicular torsion
  • Relapse with worsening renal function — nephrology referral

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
HSPPalpable purpura (buttocks/legs), arthralgia, abdominal pain, haematuriaClinical, urine dip, U&Es
Meningococcal diseaseNon-blanching rash, toxic child, feverBlood culture, LP
ITPPetechiae/bruising, low platelets, well childFBC (low platelets)
NAIUnexplained bruising, inconsistent historySafeguarding assessment
IgA nephropathyHaematuria, no rash/joints/abdominal painRenal biopsy
Kawasaki diseaseFever, conjunctivitis, rash, mucous membrane changesClinical, echo

Diagnosis / Investigation

Bedside

  • Urine dipstick: Haematuria, proteinuria — at diagnosis and weekly for 4 weeks, then monthly for 6-12 months
  • Blood pressure: Monitor throughout

Bloods

  • FBC: Platelets NORMAL (distinguishes from ITP)
  • U&Es: Renal function
  • CRP/ESR: May be mildly elevated
  • IgA: Elevated in ~50% (supports diagnosis but not diagnostic)
  • Coagulation: Normal
  • ASOT/throat swab: If preceding streptococcal infection suspected

Imaging

  • USS abdomen: If severe abdominal pain — exclude intussusception
  • Doppler USS testes: If scrotal swelling — exclude torsion

Special Tests

  • Urine protein:creatinine ratio (uPCR): Quantify proteinuria if dipstick positive
  • Renal biopsy: Only if progressive renal impairment, heavy proteinuria (uPCR >200), or nephrotic syndrome — IgA mesangial deposits
  • Skin biopsy: Rarely needed — leucocytoclastic vasculitis with IgA deposits

Management

Non-pharmacological

  • Supportive care: Rest, adequate hydration, elevation of affected limbs
  • Monitoring: Weekly urine dipstick and BP for 4 weeks; then monthly for 6-12 months

Pharmacological

  • Analgesia: Paracetamol 15mg/kg QDS + ibuprofen 10mg/kg TDS (if no renal involvement)
  • Prednisolone 1-2mg/kg/day (max 40mg): Consider for severe abdominal pain or scrotal pain; does NOT prevent nephritis
  • ACEi (ramipril): If significant proteinuria — reduces proteinuria and slows renal progression

Renal Involvement Management

  • Mild (microscopic haematuria/mild proteinuria): Monitor; usually resolves
  • Moderate (heavy proteinuria/macroscopic haematuria): Nephrology referral; ACEi
  • Severe (nephrotic syndrome/declining renal function): Immunosuppression (cyclophosphamide, mycophenolate) — guided by renal biopsy

Referral Criteria

  • Heavy proteinuria (uPCR >200) — paediatric nephrology
  • Declining renal function — nephrology urgently
  • Hypertension — nephrology
  • Severe abdominal pain not responding to steroids — surgical review (intussusception)
  • Scrotal swelling — urology if torsion cannot be excluded

Prognosis

  • Self-limiting: ~95% resolve within 4-6 weeks
  • Relapse: ~30% have at least one relapse (usually milder)
  • Renal involvement: ~40% have haematuria/proteinuria; <5% progress to significant renal disease; <1% develop ESRD
  • Long-term renal follow-up: Monitor for 12 months; late-onset nephritis can occur weeks to months after initial presentation
  • Pregnancy: Women with history of HSP nephritis have increased risk of hypertension and proteinuria in pregnancy

Other Relevant Information

HSP Monitoring Schedule

TimingAssessment
DiagnosisUrine dipstick, BP, U&Es, FBC
Weekly × 4 weeksUrine dipstick, BP
Monthly × 6-12 monthsUrine dipstick, BP
If urine abnormaluPCR, U&Es, nephrology referral

EULAR/PRINTO/PRES Classification Criteria

CriterionDetail
MandatoryPurpura (palpable) or petechiae predominantly on lower limbs
Plus ≥1 of:
Diffuse abdominal pain
Arthritis or arthralgia
Renal involvement (haematuria/proteinuria)
IgA on biopsy (skin or renal)